MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Net Margin
MicroTech Medical Hangzhou Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
|
2.5B HKD |
-49%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
226.5B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.2B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
146.4B USD |
11%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
138.7B USD |
13%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.5B USD |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66B USD |
8%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
56.3B EUR |
9%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
41.7B USD |
77%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
285.3B CNY |
33%
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
36.6B USD |
10%
|
MicroTech Medical Hangzhou Co Ltd
Glance View
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on MicroTech Medical Hangzhou Co Ltd's most recent financial statements, the company has Net Margin of -49.1%.
You don't have any saved screeners yet